A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.

The agency cleared CSL’s hereditary angioedema drug days after “resource constraints” delayed a rival medicine. Elsewhere, ...

Embattled genetic testing company 23andMe has been fined £2.3m ($3.1m) by the UK’s privacy regulator for failing to protect ...

Penalty follows year-long probe into flaws that allowed attack to affect so many The UK's data watchdog is fining beleaguered ...

Testing firm 23andMe has been fined more than £2m for failing to protect the sensitive personal and genetic data of more than ...

DNA testing firm 23andMe has been fined £2.31m by a UK watchdog over a data breach in 2023 which affected thousands of people ...

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...

California says the sale of 23andMe to a nonprofit formed by the company's former CEO would skirt a state law specifically ...

The genetic testing company 23andMe is being fined £2.31m by the UK's privacy watchdog over their 2023 data breach that saw ...

The FTSE 100 faces a stern test of its new high levels this week, with Israel-Iran tensions still running high and Tehran ...

Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...